With reference to the earlier letter dated October 16, 2014 regarding Termination of the Company's Global Depository Receipts Programme, In this regard, Ranbaxy Laboratories Ltd has now informed BSE that the Company have received a letter on October 31, 2014 from the Luxembourg Stock Exchange (LSE) (where GDS of the Company are listed) intimating that in view of the termination of the Deposit Agreement on December 15, 2014, they will de-list the GDS from the official list of the LSE and withdraw the trading of GDS on the Euro MTF Market of the LSE with effect from December 15, 2014.
|